L10: Bone stem cells Flashcards
(11 cards)
bone
Bones vary by: shape, size, symmetry.
Symmetry is established in utero, patterned by HOX genes.
Embryonic development: More bones exist early and fuse over time.
Developmental origins:
Cranial neural crest β bones of the head
Mesoderm β rest of the skeleton
𧬠Bone Cell Types
Osteoblasts: build bone
Osteoclasts: resorb (break down) bone
They crosstalk with osteoblasts for bone remodeling
Osteocytes: mature bone cells derived from osteoblasts
Osteoprogenitor cells: stem cells that give rise to osteoblasts
Lining cells: inactive osteoblasts on bone surfaces
Chondrocytes: form cartilage
π§ Growth & Regulation
Bone growth is controlled by:
Cells & signalling molecules
Cell-cell interactions
Pathological conditions (e.g. disease states)
ποΈ Bone Functions
Living, dynamic tissue
Constant remodelling
Support & structure
Muscle attachment
Site of haematopoiesis (blood cell production in marrow)
Mineral reservoir: stores calcium, phosphate, etc.
Helps maintain mineral homeostasis
Osteoblasts also help regulate bloodβbone interactions
π¦· Special Note
Bone in teeth is mineralised like skeletal bone.
bone cells
Osteoblasts
Function: Bone-forming cells
Shape: Cuboidal, polarised (nucleus on one side; RER & Golgi on the other)
Location: Sit on bone surface
Size: Large
Secrete: Mainly Type I collagen (forms osteoid)
Osteoid: Unmineralised bone matrix β later mineralised to form bone
Fate: Become osteocytes once embedded in matrix
𧬠Osteocytes
Former osteoblasts embedded in mineralised matrix
Long-lived
Function: Maintain bone health; communicate with each other via canaliculi
π Osteoclasts
Function: Bone-resorbing cells
Origin: Multinucleated cells (formed by fusion)
Feature: Ruffled border increases surface area
Mechanism: Secretes HβΊ and Clβ» ions β forms HCl
HCl dissolves bone mineral (acid demineralisation)
Dysfunction: Poor resorption due to lack of protons, nuclei, or enzymes
π± Cell Origins
Osteoblasts & Chondrocytes: Derived from Mesenchymal Stem Cells (MSCs)
Signals (e.g. growth factors) activate lineage-determining genes to guide differentiation
osteocyte differentiation pathway
MSC β Osteocyte Differentiation Pathway
1. Mesenchymal Stem Cell (MSC)
β¬οΈ Signals activate transcription factors:
Runx2
Osterix (Osx)
β¬οΈ
- Osteoprogenitor Cell
Early committed to bone lineage
β¬οΈ
- Pre-Osteoblast / Transitory Osteoblast
Expresses Alkaline Phosphatase (ALP)
Preparing bone matrix
β¬οΈ
- Mature Osteoblast
Secretes Osteocalcin (bone matrix protein)
Lays down osteoid (unmineralised matrix)
β¬οΈ
- Osteocyte (embedded in bone)
Terminally differentiated
Expresses Smp1 and Sclerostin (Sost)
Maintains bone homeostasis
osteoclasts
Osteoclast Lineage & Differentiation
Origin:
Osteoclasts are derived from haematopoietic stem cells (HSCs)
Specifically from the monocyte/macrophage lineage (phagocytic cells)
Key Signals for Differentiation:
Macrophage Colony-Stimulating Factor (M-CSF)
β€· Drives HSCs β macrophage precursors
RANKL (Receptor Activator of Nuclear Factor ΞΊB Ligand)
β€· Stimulates precursors to become osteoclasts
Osteoclast Features:
Multinucleated
Phagocytic (related to macrophages)
Responsible for bone resorption
ossification
Endochondral Ossification
β‘οΈ Bones formed via a cartilage intermediate
β‘οΈ Needed for long bones (e.g. arms, legs) and vertebrae
β‘οΈ No cartilage = no bone in this process
π Steps (in order):
Formation of cartilage model
Cartilage takes the shape of future bone
Cartilage matures and mineralises
Formation of bony collar
Around midshaft (diaphysis), cartilage starts to be replaced
Periosteum forms
Outer covering of developing bone
Capillary invasion
Blood vessels grow into the cartilage
Osteoclast migration and invasion
Haematopoietic cells (from blood) enter β form osteoclasts
Middle part is resorbed to make room for bone marrow
Primary ossification center forms
In the diaphysis (shaft)
Secondary ossification centers form
In the epiphyses (ends of bone)
πΆ Intramembranous Ossification
β‘οΈ Bones formed directly from stem cells (no cartilage intermediate)
β‘οΈ Used for flat bones of the skull, calvaria, clavicle
π Steps (in order):
Bone forms in a βmembraneβ or cell condensation
Calvaria in embryo starts as islands of bone
These islands later remodel to form skull cap
Direct formation of osteoblast precursors
Periosteum forms (outer layer)
Differentiation to osteoblasts
Matrix deposition and mineralisation
Osteoblasts lay down osteoid β later mineralised
Vascularisation
Blood vessels invade the new bone
Continued growth and remodelling
secondary ossification
After birth, secondary ossification centers form at the ends of long bones, called the epiphyses.
This is separate from the primary ossification center, which is in the diaphysis (shaft).
These centers allow the ends of bones to grow and develop properly.
Growth plates (epiphyseal plates) remain between the epiphysis and diaphysis to allow longitudinal growth during childhood and adolescence.
Eventually, these plates fuse, ending bone growth.
π In short:
Secondary ossification = bone formation at epiphyses (bone ends) after birth
Epiphysis = end part of a long bone, initially growing separately from the shaft
why does remodelling occur
Bone remodelling
Why remodel?
Calcium homeostasis. 3 organs mediating blood calcium level: bone, gut, kidney.
Hypocalcemic? (not enough ca in blood) osteoclasts will be activated, resorb bone, mineral calcium go back into bloodstream and restore levels.
Skeletal homeostaiss/ bone mass.
Steady- state: a balance of resoprtion and formation
Unbalanced: r>f
Increased bone mass e.g: osteosclerosis
f>r bone loss diseases e.g: osteoporosis
Adaptation- mechanical forces. Bones constantly under mechanical forces. Limbs, lower limbs more mechanically loaded than skull bone i.e some under more force than others?
Compression (pressing together)
Tension (pulling apart)
Torsion (twisting)
Shear (tearing across)
ARF
Occurs in cycles: Activation β Resorption β Formation (ARF)
Involves the Basic Multicellular Unit (BMU) β coordinated group of cells
πΉ 1. Activation
Quiescent (inactive) osteocytes/lining cells sense damage or signals.
They send signals to recruit osteoclast precursors.
πΉ 2. Resorption
Osteoclasts differentiate and activate.
Form ruffled border and sealing zone.
Secrete acid (HβΊ, Clβ») to dissolve bone mineral.
Osteoclasts undergo apoptosis after resorption.
πΉ 3. Reversal Phase
Area is cleaned and prepared for new bone.
Signals (e.g. from dying osteoclasts) recruit osteoblast precursors.
πΉ 4. Formation
Osteoblasts proliferate, then lay down osteoid (new bone matrix).
Matrix mineralises to form mature bone.
Some osteoblasts become embedded β become osteocytes.
Surface returns to lining/quiescent osteocytes until next cycle.
π Coupling
Osteoblasts and osteoclasts regulate each other through feedback signals.
This ensures balanced bone loss and formation.
regulating remodelling
Regulation of Remodelling
Hormones (e.g. PTH, calcitonin, oestrogen)
Cytokines & growth factors
Local signalling molecules (e.g. RANKL, OPG)
Transcription factors (e.g. Runx2)
egulation of Bone Remodelling: Mechanical Loading
π Mechanical Stress & Bone
Bone architecture adapts to mechanical demands.
Stress-bearing determines bone mass and 3D structure.
Different bones experience different loading forces, so are regulated differently.
βοΈ How It Works
More mechanical loading β more bone formation
Less mechanical loading (e.g. bed rest, microgravity) β bone resorption
π§ Osteocytes = Mechanosensors
Osteocytes detect mechanical strain in bone.
Send signals to stimulate or suppress osteoblasts/osteoclasts.
Bone is laid down along lines of greatest compressive or tensile stress (Wolffβs Law).
π Key Concept
External forces determine internal bone remodelling.
osteoporosis
Osteoporosis
Bone Fragility: Bones break easily due to weakness and loss of bone mass.
Mechanism:
Increased osteoclast activity β Excessive bone resorption.
Disruption of bone remodelling balance β More resorption than formation.
Result: Weak bones that are prone to fractures.
βοΈ Key Factor: Estrogen Deficiency
Menopause β Estrogen deficiency β Increased osteoclast activity β Accelerated bone loss.
π Therapy for Osteoporosis
Antiresorptive Therapy:
Goal: Reduce bone resorption.
Examples: Bisphosphonates, Denosumab.
Anabolic Therapy:
Goal: Promote bone formation.
Examples: Teriparatide (parathyroid hormone).
𧬠Targeting Cell Differentiation
Decrease HSC differentiation β Reduces osteoclast (OC) activity.
Increase MSC differentiation β Promotes osteoblast (OB) formation.
sclerosteosis
High Bone Mass (HBM)
Sclerosteosis: A rare genetic disorder characterized by high bone mass.
Cause: Mutation in the sclerostin (SOST) gene β Loss of function of sclerostin.
Effect: Unregulated bone formation leads to increased bone mass.
π¬ Sclerostin
Gene: SOST (osteocyte-specific gene)
Role: Secreted by osteocytes, regulates bone formation.
Inhibits bone formation by downregulating Wnt signalling (a pathway that promotes bone growth).
ποΈ Mechanical Loading & Sclerostin
Mechanical loading (e.g., weight-bearing exercise) decreases sclerostin secretion.
Effect: Reduced sclerostin β Increased bone formation.
How: Increased Wnt signalling promotes osteoblast activity, leading to more bone formation.
π Therapeutic Target: Anti-sclerostin Antibody
Romosozumab: An anti-sclerostin antibody.
Action: Inhibits sclerostin β Bone anabolic effect β Increases bone formation